Status:
COMPLETED
A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)
Lead Sponsor:
University of Michigan Rogel Cancer Center
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Radiation-induced liver disease (RILD) is a syndrome characterized by the development of anicteric ascites approximately 2 weeks to 4 months after hepatic irradiation. Previous studies have shown that...
Detailed Description
Early, but subclinical physiologic changes in the liver may be associated with the future development of RILD. There are currently limited data on how a local change in hepatic function associates wit...
Eligibility Criteria
Inclusion
- cancer patients undergoing radiation of the Liver
- women and men who agree to avoid pregnancy
- life expectancy of at least 6 months
Exclusion
- pregnant women
- breatsfeeding women
- prisoners
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT01519232
Start Date
August 1 2008
End Date
May 1 2014
Last Update
May 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States, 48109-5010